AAHRPP Accredits Three More Research Organizations
WASHINGTON, D.C.âThe Association for the Accreditation of Human Research Protection Programs (AAHRPP) announced that it has accredited three more research organizations, including its first in Hawaii-the 10-campus University of Hawaii System.
The newly accredited organizations are:
- Broad Institute of MIT and Harvard, Cambridge, Massachusetts
- Central Michigan University, Mount Pleasant, Michigan
- University of Hawaii System, Honolulu, Hawaii
“Today we welcome a biomedical and genomic research center, a public research university, and a statewide university system-all of which will have stronger research protection programs because of their commitment to AAHRPP’s high standards,” AAHRPP President and CEO Elyse I. Summers said. “With these latest accreditations, once again we demonstrate the universal application and value of AAHRPP accreditation.”
To date, 241 organizations-including 45 international entities-have earned AAHRPP accreditation. Accredited organizations must show that they have built extensive safeguards into every level of their research operation and that they adhere to high standards for research. In today’s global, collaborative research enterprise, organizations increasingly rely on AAHRPP accreditation status to help identify trusted research partners.
AAHRPP has accredited organizations across the United States and in Belgium, Brazil, Canada, China, India, Mexico, Republic of Korea, Saudi Arabia, Singapore, South Africa, Taiwan and Thailand. All major U.S. independent institutional review boards have earned AAHRPP accreditation. In addition, more than 60 percent of U.S. research-intensive universities and over 65 percent of U.S. medical schools are either AAHRPP accredited or have begun the accreditation process. The National Institutes of Health, the world’s largest public funder of research, has earned accreditation, as has Pfizer, Inc., the largest industry sponsor of clinical research.
About AAHRPP: A nonprofit organization, AAHRPP provides accreditation for organizations that conduct or review human research and can demonstrate that their protections exceed the safeguards required by the U.S. government. To learn more, visit here.
FOR MORE INFORMATION CONTACT:
Sarah Kiskaddon
Vice President, Global Development and Public Affairs
skiskaddon@aahrpp.org
(202) 783-1112
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
